Tomeglovir

Drug Profile

Tomeglovir

Alternative Names: BAY-38-4766

Latest Information Update: 06 Oct 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bayer
  • Class Antivirals
  • Mechanism of Action DNA inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cytomegalovirus infections

Most Recent Events

  • 06 Oct 2006 Discontinued - Phase-II for Cytomegalovirus infections treatment in Germany (PO)
  • 06 Oct 2006 Discontinued - Phase-II for Cytomegalovirus infections treatment in USA (PO)
  • 06 May 2003 Data presented at the 16th International Conference on Antiviral Research (ICAR-2003) have been added to the adverse events, pharmacokinetics and Viral Infections pharmacodynamics sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top